{"id":"azithromycin-or-placebo-tablets","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal pain)"},{"rate":"1-3","effect":"Headache"},{"rate":"rare","effect":"QT prolongation"},{"rate":"1-3","effect":"Vaginitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin binds to the bacterial 50S ribosomal subunit and inhibits peptide translocation, preventing protein synthesis and leading to bacteriostatic effects. Beyond its antimicrobial properties, azithromycin has immunomodulatory effects including reduction of inflammatory cytokines and mucus hypersecretion, which may be therapeutically relevant in chronic inflammatory airway diseases.","oneSentence":"Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:28:04.948Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections (approved indication)"},{"name":"Chronic airway inflammation and bronchiectasis (investigational use at Rigshospitalet)"}]},"trialDetails":[{"nctId":"NCT05157685","phase":"PHASE3","title":"Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2022-11-21","conditions":"Sinusitis, Chronic, Sinus Infection Chronic","enrollment":230},{"nctId":"NCT06715150","phase":"PHASE4","title":"Non-Surgical Treatment of Peri-implantitis with Systemic Azithromycin or Placebo","status":"NOT_YET_RECRUITING","sponsor":"University of Santiago de Compostela","startDate":"2025-01-10","conditions":"Peri-implantitis","enrollment":52},{"nctId":"NCT03871491","phase":"PHASE3","title":"Azithromycin-Prevention in Labor Use Study (A-PLUS)","status":"COMPLETED","sponsor":"NICHD Global Network for Women's and Children's Health","startDate":"2020-09-01","conditions":"Maternal Death, Maternal Infections Affecting Fetus or Newborn, Neonatal SEPSIS","enrollment":58747},{"nctId":"NCT05337566","phase":"NA","title":"Does Additional Use of Preoperative Azithromycin Decrease Posthysterectomy Infections","status":"RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2022-09-05","conditions":"Infection Post Op, Hysterectomy, Antibiotics","enrollment":2278},{"nctId":"NCT03341273","phase":"NA","title":"Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-12-08","conditions":"Lower Respiratory Tract Infection","enrollment":514},{"nctId":"NCT03248297","phase":"PHASE4","title":"Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2018-01-12","conditions":"Postpartum Sepsis, Postpartum Endometritis, Postpartum Fever","enrollment":756},{"nctId":"NCT03199547","phase":"PHASE3","title":"Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2017-10-21","conditions":"Neonatal SEPSIS","enrollment":11985},{"nctId":"NCT03618108","phase":"PHASE2","title":"Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease","status":"TERMINATED","sponsor":"Cadrock Pty. Ltd.","startDate":"2018-04-04","conditions":"Coronary Heart Disease, Chlamydophila Pneumoniae Infections","enrollment":20},{"nctId":"NCT04150250","phase":"PHASE2","title":"Cholera Anti-Secretory Treatment Trial","status":"COMPLETED","sponsor":"PATH","startDate":"2019-11-04","conditions":"Cholera","enrollment":47},{"nctId":"NCT04349592","phase":"NA","title":"Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19","status":"COMPLETED","sponsor":"Hamad Medical Corporation","startDate":"2020-04-14","conditions":"Covid19","enrollment":456},{"nctId":"NCT04403646","phase":"NA","title":"Tannin Specific Natural Extract for COVID-19 Infection","status":"TERMINATED","sponsor":"Hospital de Clinicas José de San Martín","startDate":"2020-06-12","conditions":"COVID-19, SARS-CoV 2, Coronavirus Infection","enrollment":124},{"nctId":"NCT04171388","phase":"PHASE4","title":"Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2020-03-01","conditions":"Low Birthweight, Preterm Birth, Maternal; Malnutrition, Affecting Fetus","enrollment":""},{"nctId":"NCT04405921","phase":"PHASE3","title":"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19","status":"UNKNOWN","sponsor":"Centre Hôpital Universitaire Farhat Hached","startDate":"2020-07","conditions":"SARS-CoV-2 Pneumonia, COVID-19","enrollment":200},{"nctId":"NCT00322465","phase":"PHASE2","title":"NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-11","conditions":"Urethritis","enrollment":305},{"nctId":"NCT00358462","phase":"PHASE3","title":"Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2007-01","conditions":"Urethritis","enrollment":606},{"nctId":"NCT01074554","phase":"PHASE1, PHASE2","title":"Trial of Antimycobacterial Therapy in Sarcoidosis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-02","conditions":"Sarcoidosis","enrollment":30},{"nctId":"NCT00944515","phase":"NA","title":"Efficacy of Azithromycin Prophylaxis in Preventing Recurrent Acute Sinusitis in Children","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2009-08","conditions":"Sinusitis","enrollment":40},{"nctId":"NCT02269644","phase":"PHASE3","title":"A P3 Comparator Trial in Community Acquired Bacterial Pneumonia","status":"WITHDRAWN","sponsor":"Durata Therapeutics Inc., an affiliate of Allergan plc","startDate":"2015-11","conditions":"Community Acquired Pneumonia","enrollment":""},{"nctId":"NCT00431964","phase":"PHASE4","title":"Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa","status":"COMPLETED","sponsor":"CF Therapeutics Development Network Coordinating Center","startDate":"2007-02","conditions":"Cystic Fibrosis","enrollment":263},{"nctId":"NCT02215460","phase":"PHASE4","title":"Treatment of Periodontitis by Conventional 4 Weekly Sections or Within 24 Hours","status":"COMPLETED","sponsor":"University of Taubate","startDate":"2012-04","conditions":"Periodontitis","enrollment":130},{"nctId":"NCT02107274","phase":"PHASE4","title":"Efficacy of Azithromycin in Treatment of Bronchiectasis","status":"COMPLETED","sponsor":"Penang Hospital, Malaysia","startDate":"2011-11","conditions":"Bronchiectasis","enrollment":78},{"nctId":"NCT00411736","phase":"PHASE4","title":"Scandinavian Cystic Fibrosis Azithromycin Study","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2008-05","conditions":"Cystic Fibrosis","enrollment":45},{"nctId":"NCT00644176","phase":"PHASE2","title":"A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery","status":"COMPLETED","sponsor":"Pfizer","startDate":"2004-11","conditions":"Pharmacokinetics","enrollment":66}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16645,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Project number HSA06-20/1"],"phase":"marketed","status":"active","brandName":"Azithromycin or placebo tablets","genericName":"Azithromycin or placebo tablets","companyName":"Rigshospitalet, Denmark","companyId":"rigshospitalet-denmark","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Used for Bacterial infections (approved indication), Chronic airway inflammation and bronchiectasis (investigational use at Rigshospitalet).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}